Post-marketing Safety Study in Participants of All Pathologies Who Receive Gadolinium-Based Contrast Agents (GBCAs) for Contrast-Enhanced Magnetic Resonance Imaging (MR) Examination
Clinical trial NCT03455283 · COMPLETED
Trial details
- NCT number
- NCT03455283
- Sponsor
- GE Healthcare
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-12-17
- Primary completion
- 2019-11-11
- Enrollment
- 2118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.